RIA
AMED

Realta Investment Advisors’s Amedisys AMED Stock Holding History

Realta Investment Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-85
Closed -$14K – 340
2019
Q4 		$14K Hold
85
– – ﹤0.01% 1036
2019
Q3 		$11K Buy
+85
New +$11.1K ﹤0.01% 1081

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Realta Investment Advisors's AMED Position: Q1 2020 in Review

Realta Investment Advisors sold out of Amedisys (AMED) in Q1 2020, closing a stake of 85 shares — an estimated $14K sold.

Realta Investment Advisors first reported a position in AMED in Q3 2019 and held it in 2 quarters. The position peaked at $14K in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Realta Investment Advisors reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 85 Amedisys shares in Q1 2020, an estimated $14K.
  • Realta Investment Advisors first reported a position in Amedisys in Q3 2019 and held it in 2 quarters.
  • Realta Investment Advisors's Amedisys position peaked at $14K in Q4 2019.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.